<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/316"/><api:result><api:object category="publication" id="316" last-affected-when="2024-03-14T05:51:49.807+00:00" last-modified-when="2024-03-14T05:51:49.807+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/316" created-when="2010-05-17T13:46:16.94+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-01-29</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518159" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjp.0702520" last-modified-when="2023-11-04T10:27:56.857+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;
&lt;jats:list list-type="explicit-label"&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;Phosphodiesterase (PDE) 4 inhibitors have been shown to inhibit eosinophil PDE4 activity &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; and accumulation of eosinophils in experimental airways inflammation. However, direct effects on eosinophil trafficking have not been studied in detail and it is not known if activity &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; translates into efficacy &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt;. In the present study, we compared the activity of five PDE4 inhibitors &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; and against trafficking of &lt;jats:sup&gt;111&lt;/jats:sup&gt;In‐eosinophils in cutaneous inflammation in the guinea‐pig.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;The rank order of potency for inhibition of PDE4 activity in guinea‐pig eosinophil, neutrophil and macrophage, and human neutrophil lysates was RP73401&amp;gt;SB207499&amp;gt;CDP840&amp;gt;rolipram&amp;gt;LAS31025. On TNFα production by human PBMC, all inhibitors with the exception of rolipram showed potency similar to their effect on neutrophil lysates.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;In a brain cerebellum binding assay, the rank order of potency at displacing [&lt;jats:sup&gt;3&lt;/jats:sup&gt;H]‐rolipram was RP73401&amp;gt;rolipram&amp;gt;SB207499&amp;gt;CDP840&amp;gt;LAS30125.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;Trafficking of &lt;jats:sup&gt;111&lt;/jats:sup&gt;In‐eosinophils to skin sites injected with PAF, ZAP or antigen in sensitized sites was inhibited by oral administration of all PDE4 inhibitors. The rank order of potency was RP73401=rolipram&amp;gt;LAS31025&amp;gt;SB207499&amp;gt;CDP840.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;With the exception was RP73401, which was the most potent compound in all assays, there was no clear relationship between activity of PDE4 inhibitors &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; and capacity to inhibit eosinophil trafficking &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt;. Thus, we conclude that &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; activity of PDE4 inhibitors does not predict &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt; efficacy in an experimental model of eosinophil trafficking.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;/jats:list&gt;
&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:italic&gt;British Journal of Pharmacology&lt;/jats:italic&gt; (1999) &lt;jats:bold&gt;126&lt;/jats:bold&gt;, 1863–1871; doi:&lt;jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0702520"&gt;10.1038/sj.bjp.0702520&lt;/jats:ext-link&gt;&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>Nicola</api:first-names><api:separate-first-names><api:first-name>Nicola</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>Mauro M</api:first-names><api:separate-first-names><api:first-name>Mauro</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>Julie</api:first-names><api:separate-first-names><api:first-name>Julie</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>Jadwiga M</api:first-names><api:separate-first-names><api:first-name>Jadwiga</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>Ruth E</api:first-names><api:separate-first-names><api:first-name>Ruth</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DMT</api:initials><api:first-names>David MT</api:first-names><api:separate-first-names><api:first-name>David</api:first-name><api:first-name>M</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>Robert W</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>Paul G</api:first-names><api:separate-first-names><api:first-name>Paul</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5381</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjp.0702520</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>28</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity &lt;i&gt;in vitro&lt;/i&gt; and eosinophil trafficking &lt;i&gt;in vivo&lt;/i&gt;</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="1608768" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032903424" last-modified-when="2022-09-14T05:02:32.563+01:00"><api:citation-count>22</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1. Phosphodiesterase (PDE) 4 inhibitors have been shown to inhibit eosinophil PDE4 activity in vitro and accumulation of eosinophils in experimental airways inflammation. However, direct effects on eosinophil trafficking have not been studied in detail and it is not known if activity in vitro translates into efficacy in vivo. In the present study, we compared the activity of five PDE4 inhibitors in vitro and against trafficking of 111In-eosinophils in cutaneous inflammation in the guinea-pig. 2. The rank order of potency for inhibition of PDE4 activity in guinea-pig eosinophil, neutrophil and macrophage, and human neutrophil lysates was RP73401 &gt; SB207499 &gt; CDP840 &gt; rolipram &gt; LAS31025. On TNFα production by human PBMC, all inhibitors with the exception of rolipram showed potency similar to their effect on neutrophil lysates. 3. In a brain cerebellum binding assay, the rank order of potency at displacing [3H]-rolipram was RP73401 &gt; rolipram &gt; SB207499 &gt; CDP840 &gt; LAS30125. 4. Trafficking of 111In-eosinophils to skin sites injected with PAF, ZAP or antigen in sensitized sites was inhibited by oral administration of all PDE4 inhibitors. The rank order of potency was RP73401 = rolipram &gt; LAS31025 &gt; SB307499 &gt; CDP840. 5. With the exception was RP73401, which was the most potent compound in all assays, there was no clear relationship between activity of PDE4 inhibitors in vitro and capacity to inhibit eosinophil trafficking in vivo. Thus, we conclude that in vitro activity of PDE4 inhibitors does not predict in vivo efficacy in an experimental model of eosinophil trafficking.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Chiroscience Ltd.</api:line><api:line type="city">Cambridge (ex Galt)</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35480169100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BR"><api:line type="organisation">Universidade Federal de Minas Gerais</api:line><api:line type="city">Belo Horizonte</api:line><api:line type="country">Brazil</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202391189</api:identifier></api:identifiers></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Chiroscience Ltd.</api:line><api:line type="city">Cambridge (ex Galt)</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602512701</api:identifier></api:identifiers></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">National Heart and Lung Institute</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603641068</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Chiroscience Ltd.</api:line><api:line type="city">Cambridge (ex Galt)</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36658447900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DMT</api:initials><api:first-names>DMT</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>M</api:first-name><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">National Heart and Lung Institute</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506050725</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>RW</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Stevenage Biosciences Ltd</api:line><api:line type="city">Stevenage</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005970570</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">National Heart and Lung Institute</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005788575</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10372831</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="316" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10372831" last-modified-when="2022-11-22T23:01:02.823+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1. Phosphodiesterase (PDE) 4 inhibitors have been shown to inhibit eosinophil PDE4 activity in vitro and accumulation of eosinophils in experimental airways inflammation. However, direct effects on eosinophil trafficking have not been studied in detail and it is not known if activity in vitro translates into efficacy in vivo. In the present study, we compared the activity of five PDE4 inhibitors in vitro and against trafficking of (111)In-eosinophils in cutaneous inflammation in the guinea-pig. 2. The rank order of potency for inhibition of PDE4 activity in guinea-pig eosinophil, neutrophil and macrophage, and human neutrophil lysates was RP73401 &gt; SB207499 &gt;CDP840 &gt; rolipram &gt; LAS31025. On TNFalpha production by human PBMC, all inhibitors with the exception of rolipram showed potency similar to their effect on neutrophil lysates. 3. In a brain cerebellum binding assay, the rank order of potency at displacing [3H]-rolipram was RP73401 &gt; rolipram &gt; SB207499 &gt; CDP840 &gt; LAS30125. 4. Trafficking of (111)In-eosinophils to skin sites injected with PAF, ZAP or antigen in sensitized sites was inhibited by oral administration of all PDE4 inhibitors. The rank order of potency was RP73401 = rolipram &gt; LAS31025 &gt; SB207499 &gt; CDP840. 5. With the exception was RP73401, which was the most potent compound in all assays, there was no clear relationship between activity of PDE4 inhibitors in vitro and capacity to inhibit eosinophil trafficking in vivo. Thus, we conclude that in vitro activity of PDE4 inhibitors does not predict in vivo efficacy in an experimental model of eosinophil trafficking.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Chiroscience Limited, Cambridge Science Park.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DM</api:initials><api:first-names>DM</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>RW</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10372831</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC1565970</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Pharmacol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Benzamides</api:keyword><api:keyword scheme="mesh">Cell Movement</api:keyword><api:keyword scheme="mesh">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword><api:keyword scheme="mesh">Dermatitis</api:keyword><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Macrophages</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Neutrophils</api:keyword><api:keyword scheme="mesh">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrrolidinones</api:keyword><api:keyword scheme="mesh">Rolipram</api:keyword><api:keyword scheme="mesh">Skin</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>0702520</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>29</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="881745" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10372831" last-modified-when="2021-01-19T17:54:03.22+00:00"><api:citation-count>14</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1. Phosphodiesterase (PDE) 4 inhibitors have been shown to inhibit eosinophil PDE4 activity in vitro and accumulation of eosinophils in experimental airways inflammation. However, direct effects on eosinophil trafficking have not been studied in detail and it is not known if activity in vitro translates into efficacy in vivo. In the present study, we compared the activity of five PDE4 inhibitors in vitro and against trafficking of (111)In-eosinophils in cutaneous inflammation in the guinea-pig. 2. The rank order of potency for inhibition of PDE4 activity in guinea-pig eosinophil, neutrophil and macrophage, and human neutrophil lysates was RP73401 &gt; SB207499 &gt;CDP840 &gt; rolipram &gt; LAS31025. On TNFalpha production by human PBMC, all inhibitors with the exception of rolipram showed potency similar to their effect on neutrophil lysates. 3. In a brain cerebellum binding assay, the rank order of potency at displacing [3H]-rolipram was RP73401 &gt; rolipram &gt; SB207499 &gt; CDP840 &gt; LAS30125. 4. Trafficking of (111)In-eosinophils to skin sites injected with PAF, ZAP or antigen in sensitized sites was inhibited by oral administration of all PDE4 inhibitors. The rank order of potency was RP73401 = rolipram &gt; LAS31025 &gt; SB207499 &gt; CDP840. 5. With the exception was RP73401, which was the most potent compound in all assays, there was no clear relationship between activity of PDE4 inhibitors in vitro and capacity to inhibit eosinophil trafficking in vivo. Thus, we conclude that in vitro activity of PDE4 inhibitors does not predict in vivo efficacy in an experimental model of eosinophil trafficking.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Chiroscience Limited, Cambridge Science Park.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DM</api:initials><api:first-names>DM</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>RW</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5381</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10372831</api:identifier><api:identifier scheme="pmc">PMC1565970</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Neutrophils</api:keyword><api:keyword scheme="mesh">Macrophages</api:keyword><api:keyword scheme="mesh">Skin</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Dermatitis</api:keyword><api:keyword scheme="mesh">Benzamides</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrrolidinones</api:keyword><api:keyword scheme="mesh">Rolipram</api:keyword><api:keyword scheme="mesh">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh">Cell Movement</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="2903884" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1014534638" last-modified-when="2023-11-26T08:34:08.63+00:00"><api:citation-count>20</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>Nicola</api:first-names><api:separate-first-names><api:first-name>Nicola</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Chiroscience Limited, Cambridge Science Park, Cambridge CB4 4WE</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01174345456.78</api:identifier></api:identifiers></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>Mauro M</api:first-names><api:separate-first-names><api:first-name>Mauro</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BR"><api:line type="organisation">Universidade Federal de Minas Gerais</api:line><api:line type="city">Belo Horizonte</api:line><api:line type="country">Brazil</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.012400013462.78</api:identifier></api:identifiers></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>Julie</api:first-names><api:separate-first-names><api:first-name>Julie</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Chiroscience Limited, Cambridge Science Park, Cambridge CB4 4WE</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01165561563.16</api:identifier></api:identifiers></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>Jadwiga M</api:first-names><api:separate-first-names><api:first-name>Jadwiga</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01225706755.39</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>Ruth E</api:first-names><api:separate-first-names><api:first-name>Ruth</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Chiroscience Limited, Cambridge Science Park, Cambridge CB4 4WE</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DMT</api:initials><api:first-names>David MT</api:first-names><api:separate-first-names><api:first-name>David</api:first-name><api:first-name>M</api:first-name><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01030240453.19</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>Robert W</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Stevenage Biosciences Ltd, Stevenage, SG2 8SD</api:line><api:line type="city">Stevenage</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01325210537.24</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>Paul G</api:first-names><api:separate-first-names><api:first-name>Paul</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0745306034.38</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10372831</api:identifier><api:identifier scheme="pmc">PMC1565970</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3214 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="hrcs-rac">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="mesh">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Benzamides</api:keyword><api:keyword scheme="mesh">Cell Movement</api:keyword><api:keyword scheme="mesh">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword><api:keyword scheme="mesh">Dermatitis</api:keyword><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guinea Pigs</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Macrophages</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Neutrophils</api:keyword><api:keyword scheme="mesh">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrrolidinones</api:keyword><api:keyword scheme="mesh">Rolipram</api:keyword><api:keyword scheme="mesh">Skin</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Green OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.48</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="240055" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000080023100023" last-modified-when="2024-03-14T05:51:49.81+00:00"><api:citation-count>18</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">A-4587-2008</api:identifier></api:identifiers></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DMT</api:initials><api:first-names>DMT</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>M</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>RW</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000080023100023&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702520</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702520"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702520"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">191LC</api:identifier><api:identifier scheme="pubmed">10372831</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF PHARMACOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>eosinophil</api:keyword><api:keyword>eosinophil tracking</api:keyword><api:keyword>phosphodiesterase</api:keyword><api:keyword>phosphodiesterase 4 inhibitors</api:keyword><api:keyword>rolipram</api:keyword><api:keyword>RP73401</api:keyword><api:keyword>LAS31025</api:keyword><api:keyword>SB207499</api:keyword><api:keyword>CDP840</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity &lt;i&gt;in vitro&lt;/i&gt; and eosinophil trafficking &lt;i&gt;in vivo&lt;/i&gt;</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record><api:record format="native" id="22643" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000080023100023" last-modified-when="2014-07-25T11:02:18.233+01:00"><api:citation-count>13</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cooper</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Teixeira</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Warneck</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Miotla</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wills</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Macari</api:last-name><api:initials>DMT</api:initials><api:first-names>DMT</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>M</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gristwood</api:last-name><api:initials>RW</api:initials><api:first-names>RW</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J PHARMACOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>eosinophil</api:keyword><api:keyword>eosinophil tracking</api:keyword><api:keyword>phosphodiesterase</api:keyword><api:keyword>phosphodiesterase 4 inhibitors</api:keyword><api:keyword>rolipram</api:keyword><api:keyword>RP73401</api:keyword><api:keyword>LAS31025</api:keyword><api:keyword>SB207499</api:keyword><api:keyword>CDP840</api:keyword><api:keyword>GUINEA-PIG SKIN</api:keyword><api:keyword>CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE</api:keyword><api:keyword>LOCAL EDEMA FORMATION</api:keyword><api:keyword>H-3 ROLIPRAM BINDING</api:keyword><api:keyword>RECRUITMENT IN-VIVO</api:keyword><api:keyword>CATALYTIC ACTIVITY</api:keyword><api:keyword>CUTANEOUS INFLAMMATION</api:keyword><api:keyword>ACCUMULATION</api:keyword><api:keyword>IV</api:keyword><api:keyword>ASTHMA</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1863</api:begin-page><api:end-page>1871</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>126</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Benzamides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Movement</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dermatitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Macrophages</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neutrophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyrrolidinones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Rolipram</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Skin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neutrophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Macrophages</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Skin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dermatitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Benzamides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyrrolidinones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Rolipram</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Movement</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3214 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">3',5'-Cyclic-AMP Phosphodiesterases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Benzamides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Movement</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cyclic Nucleotide Phosphodiesterases, Type 4</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dermatitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Guinea Pigs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Macrophages</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neutrophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Phosphodiesterase Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyrrolidinones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Rolipram</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Skin</api:keyword><api:keyword origin="record-data" source="wos-lite">eosinophil</api:keyword><api:keyword origin="record-data" source="wos-lite">eosinophil tracking</api:keyword><api:keyword origin="record-data" source="wos-lite">phosphodiesterase</api:keyword><api:keyword origin="record-data" source="wos-lite">phosphodiesterase 4 inhibitors</api:keyword><api:keyword origin="record-data" source="wos-lite">rolipram</api:keyword><api:keyword origin="record-data" source="wos-lite">RP73401</api:keyword><api:keyword origin="record-data" source="wos-lite">LAS31025</api:keyword><api:keyword origin="record-data" source="wos-lite">SB207499</api:keyword><api:keyword origin="record-data" source="wos-lite">CDP840</api:keyword><api:keyword origin="record-data" source="wos">eosinophil</api:keyword><api:keyword origin="record-data" source="wos">eosinophil tracking</api:keyword><api:keyword origin="record-data" source="wos">phosphodiesterase</api:keyword><api:keyword origin="record-data" source="wos">phosphodiesterase 4 inhibitors</api:keyword><api:keyword origin="record-data" source="wos">rolipram</api:keyword><api:keyword origin="record-data" source="wos">RP73401</api:keyword><api:keyword origin="record-data" source="wos">LAS31025</api:keyword><api:keyword origin="record-data" source="wos">SB207499</api:keyword><api:keyword origin="record-data" source="wos">CDP840</api:keyword><api:keyword origin="record-data" source="wos">GUINEA-PIG SKIN</api:keyword><api:keyword origin="record-data" source="wos">CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE</api:keyword><api:keyword origin="record-data" source="wos">LOCAL EDEMA FORMATION</api:keyword><api:keyword origin="record-data" source="wos">H-3 ROLIPRAM BINDING</api:keyword><api:keyword origin="record-data" source="wos">RECRUITMENT IN-VIVO</api:keyword><api:keyword origin="record-data" source="wos">CATALYTIC ACTIVITY</api:keyword><api:keyword origin="record-data" source="wos">CUTANEOUS INFLAMMATION</api:keyword><api:keyword origin="record-data" source="wos">ACCUMULATION</api:keyword><api:keyword origin="record-data" source="wos">IV</api:keyword><api:keyword origin="record-data" source="wos">ASTHMA</api:keyword><api:keyword scheme="for" origin="issn-inferred">1115 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Pharmacology &amp; Pharmacy</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-1188" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940" title="British Journal of Pharmacology"><api:records><api:record source-name="summary"><api:title>British Journal of Pharmacology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/316/relationships"/></api:object></api:result></api:response>